Cancer
Peripheral blood cultures may cause unnecessary discomfort and delays in clinical care for pediatric cancer patients, according to a recent study published in Jco Oncology Practice. Researchers at the Baylor College of Medicine in Houston, Texas, examined the utility and clinical impact of peripheral blood cultures in pediatric hematology/oncology
Cancer
Dr. Azura Deniel, a Consultant Clinical Oncologist, has made precision therapies and compassionate support available at Ampang Puteri Specialist Hospital (APSH) in Malaysia, an attractive option for Bangladeshi patients seeking advanced cancer treatment abroad. By tailoring treatment plans to each patient's unique cancer profile, Dr. Azura aims to
Cancer
A new study published in the Journal of Managed Care & Specialty Pharmacy has examined the real-world patient profile and step-up dosing process of early initiators of teclistamab for multiple myeloma in US hospitals. The research, conducted by investigators at Memorial Sloan-Kettering Cancer Center, analyzed data from the Premier Healthcare
Cancer
Research published in Laboratory Investigation presents findings on the heterogeneity of human epidermal growth factor receptor 2 (HER2) in endometrial cancer. The study, conducted at Emory University Hospital, aimed to evaluate HER2 heterogeneity at the protein and gene levels in nonserous endometrial carcinomas. The research revealed significant intratumoral heterogeneity in
Cancer
Local Specsavers store in Mexborough partnered with Macmillan Cancer Support for their World's Biggest Coffee Morning, a charity event that has raised over £310 million since its inception in 1990. The Specsavers team baked homemade cakes and hosted a cake sale, donating the proceeds to the charity. Store
Cancer
Research from Shandong University of Traditional Chinese Medicine sheds light on the critical interaction between endometrial cancer cells and tumour-associated macrophages mediated by extracellular vesicles. This interaction plays a crucial role in the proliferation, migration, and invasion of cancer cells, as well as in the polarization of macrophages towards an
Cancer
New research at the University of Kentucky has made significant breakthroughs in the treatment of endometrial cancer, a type of cancer that affects the lining of the uterus. According to the study, researchers have developed a new drug delivery system (DDS) that can encapsulate a chemotherapy drug called paclitaxel, allowing
Cancer
CatalYm, a world leader in neutralizing GDF-15 in cancer and cachexia, presented updated long-term data from its ongoing GDFATHER-1/2a trial at the European Society of Medical Oncology (ESMO) Congress 2025. The data provide further evidence that Growth Differentiation Factor-15 (GDF-15) blockade by visugromab can reverse resistance to PD-(L)
Cancer
Researchers at Fudan University in Shanghai, China have identified a key mechanism by which endometrial cancer cells evade the immune system and resist immunotherapy. The study, published in the Journal for ImmunoTherapy of Cancer, found that the enzyme O-GlcNAc transferase (OGT) plays a critical role in promoting immune evasion and
Cancer
Research conducted by the National Cancer Institute (NCI) has shown that cancer risk among people with HIV (PWH) has varied across different racial/ethnic and transmission risk groups. The study, which analyzed data from PWH aged 20 years during 2001-2019, found significant differences in cancer incidence rates among different racial/
Brain
A study conducted by researchers at the University of Occupational and Environmental Health in Fukuoka, Japan, investigated the return-to-work (RTW) rates and associated factors following endoscopic transsphenoidal surgery (eTSS) among patients with pituitary and hypothalamic tumors in Japan. The study aimed to determine the variables affecting early RTW post-surgery. The
Cancer
A new study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, suggests that exemestane, an aromatase inhibitor, may be effective in preventing endometrial cancer. The multi-center, single-arm pilot study enrolled 40 postmenopausal women with endometrial intraepithelial neoplasia (EIN) or low-grade endometrial cancer, who underwent
